期刊文献+

甲状腺髓样癌20例临床分析

Clinical analysis of medullary thyroid carcinoma :a report of 20 cases
下载PDF
导出
摘要 目的 探讨甲状腺髓样癌临床特点、诊断要点及治疗原则.方法 回顾性分析2005年1月至2012年12月20例甲状腺髓样癌患者的临床资料,全组病例均经病理证实为甲状腺髓样癌,颈淋巴结转移9例,远处转移1例,总颈部淋巴结转移率达50%.20例均行手术治疗,至少行患侧腺叶及峡部切除16例,占80% (16/20),其中行甲状腺全切除9例.结果 术后常规监测血清降钙素,复发2例.术后随访17例,超过5年者9例,5年生存率达77.8%.结论 甲状腺髓样癌术前诊断困难,多数依赖组织病理学检查确诊,强调细针穿刺细胞学检查的重要性,治疗以根治性手术为主,术后监测降钙素能及早发现局部复发和转移. Objective To investigate the clinicopathological features,diagnosis and treatment principles of medullary thyroid carcinoma(MTC).Methods The clinical data of 20 patients with MTC from January 2005 to December 2012 were retrospectively reviewed.All cases were confirmed by pathology.The total cervical lymph node metastasis rate was 50%,including 9 cases with cervical lymph node metastasis and 1 case with distant metastasis.All 20 cases were treated with operation and 80% patients(16/20) underwent lobectomy and isthmectomy at least,including 9 cases of total thyroidectomy.Results Postoperative serum calcitonin were monitored and the recurrence occurred in 2 cases.A total of 17 cases were followed up after the operation and 9 cases were followed up for more than 5 years.The 5-year survival rate reached 77.8%.Conclusion MTC is difficult to be diagnosed preoperatively and it's mainly based on the histopathological examination.The importance of preoperative fine-needle aspiration for cytology test should be emphasized.The radical operation is the predominant treatment and postoperative monitoring of calcitonin could reveal local recurrence and metastasis early.
出处 《临床外科杂志》 2013年第9期679-680,共2页 Journal of Clinical Surgery
关键词 甲状腺髓样癌 诊断 治疗 降钙素 medullary thyroid carcinoma diagnosis therapy calcitonin
  • 相关文献

参考文献8

二级参考文献44

  • 1吴毅.甲状腺髓样癌的外科治疗[J].中国普外基础与临床杂志,2006,13(3):250-251. 被引量:3
  • 2刘跃武,高维生,唐伟松.应更好地规范甲状腺癌的初次手术[J].中国普外基础与临床杂志,2006,13(3):254-255. 被引量:14
  • 3高再荣,安锐,张永学,Hans J.Biersack.核素靶向治疗在转移性甲状腺髓样癌治疗中的价值[J].中华肿瘤杂志,2006,28(8):621-624. 被引量:8
  • 4李树玲:刘科 张仑.甲状腺癌[A].见:季树玲 主编.头颈肿瘤学[C].天津:天津科学技术出版社,1993.712-761.
  • 5Kebebew E, Ituarte PHG, Siperstein AE, et al. MeduUary thyroid carcinoma : clinical characteristics, treatment, prognostic factors and a comparison of staging systems [ J ]. Cancer,2000,88 (5) : 1139.
  • 6Rohmer V, Vidal-Trecan G, Bourdelot A, et al. Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: a multicenter study of the Groupe Francais dEtude des Tumeurs Endocrines [ J]. J Clin Endocrinol Metab, 2011 ,96(3) :E509-518.
  • 7Dequanter D, Lothaire P. Medullary thyroid cancer: surgical results and prognostic factors[J]. Rev Med Liege,2010, 65(7-8) :450-452.
  • 8Brandao LG, Cavalheim BG, Junqueira CR. Prognostic influence of clinical and pathological factors in medullary thyroid carcinoma: a study of 53 cases. [J]. Clinics (Sao Paulo). 2009;64(9) :849-856.
  • 9Hazard JB, Hawk WA, Crite G. Medullary (solid) carcinoma of the thyroid; a elinicopathologic entity [ J ]. J Clin Endocrinol Metab.1959 .19(1) :152-161.
  • 10Corsello SM, Lovicu RM, Migneco MG. et al. Diagnostic approach, genetic screeningand pronostic factord of medullary thyroid carci- noma [ J ]. Rays,2000,25 ( 2 ) : 257-266.

共引文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部